Lung Neoplasm Clinical Trial
Official title:
Three-Dimensional Printing of Navigational Template in Localization of Small Pulmonary Nodule: A Prospective, Randomized, Controlled, Non-inferiority Trial
Verified date | December 2018 |
Source | Shanghai Pulmonary Hospital, Shanghai, China |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The trial is to evaluate the efficacy and safety of three-dimensional printed navigational template in the clinical application of small peripheral lung nodule localization.
Status | Completed |
Enrollment | 200 |
Est. completion date | October 25, 2017 |
Est. primary completion date | October 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 80 Years |
Eligibility |
Inclusion Criteria: 1. Aged from 19 to 80 years 2. lesions located in peripheral lung tissue which can be removed by wedge resection 3. The maximum diameter of the lesion is no more than 20 mm. 4. Research assistant consulted with the patient's surgeon to confirm the necessity of lung nodule localization 5. Informed consent was signed voluntarily. Exclusion Criteria: 1. nodule located in the scapula region. 2. there were two or more lung nodules needed to be localized. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Pulmonary Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Chang Chen |
China,
Zhang L, Li M, Li Z, Kedeer X, Wang L, Fan Z, Chen C. Three-dimensional printing of navigational template in localization of pulmonary nodule: A pilot study. J Thorac Cardiovasc Surg. 2017 Dec;154(6):2113-2119.e7. doi: 10.1016/j.jtcvs.2017.08.065. Epub 2017 Sep 1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of Lung Nodule Localization | Localization accuracy was defined by the localizer deviation between the hookwire and the center of the target nodule. (The deviation was measured using CAD software after downloading the CT images from the Picture Archiving and Communication Systems.) | From the time of completing final CT scan, assessed up to 2 days. | |
Secondary | Procedural Duration of the Nodule Localization | Procedural duration was derived from CT scan parameters, which was calculated as the time length between the initial and final scan. | From the time of completing final CT scan, assessed up to 1 hour. | |
Secondary | Radiation Dose | Radiation dosage was read on the monitor screen of CT scanner and converted to effective dosage. | From the time of completing final CT scan, assessed up to 1 hour. | |
Secondary | Complication Rate | Pnuemothorax related to lung nodule localization | From the time of completing final CT scan, assessed up to 2 days. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Completed |
NCT04508270 -
Significance of Early Mobilization After VATS-L
|
||
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Completed |
NCT05469425 -
Home-based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery
|
N/A | |
Recruiting |
NCT05046067 -
Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery
|
N/A | |
Terminated |
NCT03090880 -
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
|
Phase 3 | |
Recruiting |
NCT05596760 -
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
|
N/A | |
Completed |
NCT02498860 -
Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung
|
Phase 2 | |
Not yet recruiting |
NCT06024538 -
Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
|
||
Recruiting |
NCT02965300 -
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis
|
N/A | |
Completed |
NCT02616211 -
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
|
||
Recruiting |
NCT00765986 -
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
|
N/A | |
Completed |
NCT03320044 -
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
|
||
Recruiting |
NCT03655015 -
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
|
||
Completed |
NCT03741868 -
Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
|
||
Not yet recruiting |
NCT05179408 -
Telerehabilitation Following Lung Cancer
|
N/A | |
Completed |
NCT03749512 -
NLCR in Prediction of the Grade of Lung Tumor.
|
||
Recruiting |
NCT03664843 -
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
|
||
Completed |
NCT01261507 -
Reader Study of DeltaView™ Chest Radiograph Software
|
N/A | |
Terminated |
NCT01064050 -
Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers
|
Phase 4 |